Clinical Focus

• Gastroenterology
• Hepatology
• Primary liver cancer
• Chronic hepatitis B and C
• Liver transplantation

Administrative Appointments

• Editorial Board, Gastroenterology (2011 - 2014)
• Abstract review member for the Hepatitis B : Epidemiology/Prevention/Control review group, American Association for the Study of Liver Diseases (2011 - 2013)
• Director of Clinical Research, Pacific Health Foundation (2004 - present)
• Director of Continuing Medical Education, Pacific Health Foundation (2005 - present)
• Editorial Board, Digestive Diseases and Sciences (2008 - present)

Honors and Awards

• Phi Beta Kappa, University of California, Irvine (1985)
• Magna Cum Laude, University of California, Irvine (1988)
• Excellence in Teaching Award, University of California, San Diego, School of Medicine (1996)
• Advanced Hepatology Research Fellow Award, American Association for the Study of Liver Diseases (2001)

Professional Education

Postdoctoral Advisees

Robert Wong

Graduate & Fellowship Program Affiliations

• Epidemiology
• Medicine

Community and International Work

• Outreach Liver Clinics, San Jose and Los Gatos, San Jose, Los Gatos 
• Community education, outreach service, and research, San Jose 
• Epidemiology and treatment outcomes of Asian patients with chronic hepatitis B and C, San Jose, Southern California, Texas 
• Colon cancer screening in Asian Americans, San Jose 
• Song Manh 

Current Research Interests

Primary research interests include the clinical aspects, molecular epidemiology and pathogenesis of hepatocellular carcinoma with an emphasis on disease determinants, diagnostic and screening tests, and ethnic differences. The goal is to improve screening methods and treatment outcomes of patients with this cancer. Dr. Nguyen’s research interests also include the epidemiological and clinical behaviors of viral hepatitis, particularly in hepatitis C patients with novel genotypes and in understudied populations. Study designs used in past and current studies include cross-sectional studies, case control studies, multicenter clinical studies employing standardized questionnaires, and multicenter randomized controlled trials including treatment studies.

Clinical Trials

• Risk Factors and Molecular Genomics of U.S. Patients with Chronic Liver Disease &Hepatocellular CA No longer recruiting
• Evaluation of Stereotactic Radiosurgery For Liver Malignancies Completed
• Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma Terminated

Publications

• Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. Ho EY, Ha NB, Ahmed A, Ayoub W, Daugherty T, Garcia G, Cooper A, Keeffe EB, Nguyen MH. J Viral Hepat. 2012; 19 (2): e105-11
• Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Ha NB, Ha NB, Ahmed A, Ayoub W, Daugherty TJ, Chang ET, Lutchman GA, Garcia G, Cooper AD, Keeffe EB, Nguyen MH. Cancer Causes Control. 2012
• High rate of complete viral suppression with combination therapy in patients with chronic hepatitis B and prior treatment failure. Wong CR, Trinh HN, Yip B, Nguyen HA, Garcia RT, Ahmed A, Keeffe EB, Nguyen MH. J Clin Gastroenterol. 2011 Nov-Dec; 45 (10): 900-5
• Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. Nguyen LH, Ko S, Wong SS, Tran PS, Trinh HN, Garcia RT, Ahmed A, Lutchman GA, Keeffe EB, Nguyen MH. Hepatology. 2011; 53 (6): 1839-45
• Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. Ha NB, Ha NB, Garcia RT, Trinh HN, Chaung KT, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Dig Dis Sci. 2011; 56 (8): 2423-31